MedTrace Logo

Investigation on a Topical Cosmetic Pain Lotion (Egyfil) for Stiffness and Pain Relief

NCT05711953 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2023-07-20

No results posted yet for this study

Summary

The application of a novel topical formulation for the treatment of muscular pain and stiffness (Egyfil), containing hyaluronic acid, SH-Polypeptide-6 and SH-Oligopeptide-1, is investigated to evaluate efficacy and safety in 26 patients with stiffness and pain. Single-Arm, Pre-Market, interventional study.

Conditions

  • Pain
  • Muscle Rigidity

Interventions

OTHER

Egyfil Pain Lotion

Egyfil is a cosmetic product to be applied to intact skin, useful to attenuate muscolar pain and stiffness, with a novel topical formulation containing hyaluronic acid, SH-Polypeptide-6 and SH-Oligopeptide-1. The presence of sodium hyaluronate and peptides mixture promotes the pain alleviating activity and soothing properties of the product.

Sponsors & Collaborators

  • Contrad Swiss SA

    lead INDUSTRY

Principal Investigators

  • Stefano Picotti, Osteopathy · Stefano Picotti - Individual Entrepeneur

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-12
Primary Completion
2021-07-20
Completion
2021-07-20

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05711953 on ClinicalTrials.gov